Status:
TERMINATED
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace
Lead Sponsor:
Montefiore Medical Center
Conditions:
Hip Arthropathy
Regional Anesthesia
Eligibility:
All Genders
18-99 years
Brief Summary
Over 300,000 hip arthroplasties are performed each year in the United States.1 This number has been steadily increasing over the last two decades, likely due to increased life expectancy and, more sig...
Detailed Description
Hypothesis: The erector spinae plane block will decrease opioid requirements in patients undergoing hip arthroplasty as compared to patients that do not receive the block. Primary Objective: To com...
Eligibility Criteria
Inclusion
- Patients undergoing primary hip arthroplasty
- American Society of Anesthesiologists (ASA) Category 1, 2, and 3
- Patients age ≥18 years
Exclusion
- Patient refusal
- Inability to understand and sign consent
- Infection at the injection site
- Known allergy or hypersensitivity to ropivacaine or other amide local anesthetics
- Contraindication or patient refusal to get spinal anesthesia
- Thrombocytopenia (platelets \< 100,000)
- Coagulopathy (INR \> 1.4)
- Use of anticoagulant drugs that have not been discontinued in an appropriate amount of time before the surgery
- ASA Category 4 and 5
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 26 2022
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03801863
Start Date
March 1 2019
End Date
January 26 2022
Last Update
July 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center- Wakefield Campus
The Bronx, New York, United States, 10467